# HAI Via Interventionally Implanted Port Catheter Systems

> **NCT00356161** · PHASE2 · UNKNOWN · sponsor: **Charite University, Berlin, Germany** · enrollment: 100 (—)

## Conditions studied

- Colorectal Cancer
- Liver Neoplasms
- Hepatocellular Carcinoma
- Gallbladder Cancer
- Bile Duct Cancer

## Interventions

- **DEVICE:** interventionally implanted hepatic arterial port catheter

## Key facts

- **NCT ID:** NCT00356161
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-04
- **Primary completion:** —
- **Final completion:** 2008-04
- **Target enrollment:** 100 (—)
- **Last updated:** 2006-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00356161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00356161, "HAI Via Interventionally Implanted Port Catheter Systems". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00356161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*